For the quarter ending 2025-09-30, CBLL had -$16,402K decrease in cash & cash equivalents over the period. -$11,467K in free cash flow.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net loss | -13,465 | -26,420 |
| Depreciation and amortization expense | 391 | 659 |
| Non-cash lease expense | 26 | 50 |
| Stock-based compensation expense | 3,349 | 5,515 |
| Amortization of debt discount and accretion of premium on term loans | 106 | 202 |
| Accretion (amortization) of discount and premium on marketable securities | 902 | 487 |
| Change in fair value of warrant liability | 0 | 0 |
| Loss on disposal of property and equipment and recorders | -29 | -50 |
| Accounts receivable, net | -78 | 1,434 |
| Inventory | 24 | -937 |
| Prepaid expenses and other current assets | 838 | -1,229 |
| Contract costs | 276 | 351 |
| Other non-current assets | -5 | 226 |
| Accounts payable | -205 | 1,361 |
| Accrued liabilities and other current liabilities | 765 | -17 |
| Contract liabilities | -85 | 96 |
| Net cash used in operating activities | -11,098 | -18,936 |
| Purchases of recorders and related components | 94 | 288 |
| Purchases of property and equipment | 369 | 219 |
| Purchases of marketable securities | 45,981 | 142,794 |
| Proceeds from maturities of marketable securities | 39,500 | 6,000 |
| Net cash used in investing activities | -6,944 | -137,301 |
| Proceeds related to employee stock plans | 3,798 | - |
| Proceeds from debt issuance | 0 | 0 |
| Debt issuance cost | 0 | 150 |
| Payment of deferred ipo offering costs | 0 | 0 |
| Proceeds from exercise of common stock pursuant to stock option exercises | - | 2,158 |
| Net cash provided by financing activities | 1,640 | 2,008 |
| Net decrease in cash and cash equivalents | -16,402 | -154,229 |
| Cash and cash equivalents at beginning of period | 194,370 | - |
| Cash and cash equivalents at end of period | 23,739 | - |
Ceribell, Inc. (CBLL)
Ceribell, Inc. (CBLL)